Eugene Sefanov

Our country is in the midst of an opioid epidemic. We are seeing staggering statistics of drug abuse, not to mention graphic images and videos of the effects drugs are having on families and their loved ones. While the FDA has taken a serious stance in the fight against drug abuse and has even come […]

The data that SoFi leverages enables the company to be quick and efficient – two things that people value in companies. However, the data and technology that make SoFi successful also addresses some of the regulatory concerns by essentially forcing it to be blind to applications. Data is helping financial institutions with tasks like identifying […]

There’s probably no better way to introduce our new energy industry guide than by sharing the very first question David M. Rubenstein, president of The Economic Club of Washington D.C., asked John S. Watson, chairman of the board and CEO (retiring February 1, 2018) of Chevron, during an interview last year: “So, what could be […]

Living with disease and undergoing treatment can be life-changing. Patients may not understand their diseases, their treatment options, or even the implications of the medications they’re taking. The process can be confusing, complicated, and worrisome. With digital transformation becoming more sophisticated and prevalent, pharmaceutical and medical device companies have stepped up to the plate with […]

Data is king for many reasons, and the amount of data we produce every day grows exponentially. According to some estimates, 90% of the data in existence today was created within the last two years. IBM estimates that we create 2.5 quintillion bytes of data every day, or enough to fill 10 million Blu-Ray discs. […]

We’ve done many of API and microservices projects over the years, but I thought it would be nice to share what we presented at the recent CA World conference, which took place at the end of 2017. We shared the stage with TCF Bank, a client of ours. According to the company’s website, TCF Bank […]

When it comes to drug approvals, 2017 was a great year for the pharmaceutical industry. According to Reuters, the number of drugs approved in the United States was the highest number in 21 years. In fact, the 46 novel drugs that were approved was more than double what was approved in 2016. This figure doesn’t […]

Knowing for certain what the future holds is impossible. Trends, on the other hand, are more predictable. In fact, there’s probably no better indicator of emerging or future trends than recent history. That is exactly how we determined the trends we anticipate seeing in the pharmaceutical and medical device industries in 2018. This guide does […]

Predicting the future of finance is, for the most part, impossible. However, if you look back (and not that far) at the history of innovation in our industry, chances are you believe the future is bright. Consider how far we’ve advanced in just the past 60 years: Modern-day credit cards were introduced in 1950, starting […]

Now that January is here, I thought it would be neat to look back at what our readers found most interesting last month. Below are the top five blog posts Perficient’s life sciences practice wrote in December – they’re ranked in order of popularity, with number one being the most viewed piece. Shared Investigator Platform (SIP) Struggles […]

It’s been a long time in the making, but it’s finally completed. Janssen, a pharmaceutical company owned by Johnson & Johnson, just unveiled a new digital site, Cancer.com. The new site provides patients, caregivers, and loved ones with loads of content and resources. It even offers users the ability to customize and personalize the site […]

Over the last several weeks, we discussed self-driving and connected cars in-depth. At the end of the day, as the automotive industry (everything from buying and selling vehicles to the driver experience) continues to evolve in today’s digital world, bumps along the way will be normal. Car manufacturers, companies focused on the development of autonomous […]